These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1381433)
21. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Zbar B; Brauch H; Talmadge C; Linehan M Nature; 1987 Jun 25-Jul 1; 327(6124):721-4. PubMed ID: 2885753 [TBL] [Abstract][Full Text] [Related]
22. Allelotype of renal cell carcinoma. Morita R; Ishikawa J; Tsutsumi M; Hikiji K; Tsukada Y; Kamidono S; Maeda S; Nakamura Y Cancer Res; 1991 Feb; 51(3):820-3. PubMed ID: 1670999 [TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026 [TBL] [Abstract][Full Text] [Related]
24. Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization. Presti JC; Moch H; Gelb AB; Huynh D; Waldman FM J Urol; 1998 Oct; 160(4):1557-61. PubMed ID: 9751412 [TBL] [Abstract][Full Text] [Related]
25. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478 [TBL] [Abstract][Full Text] [Related]
26. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Bugert P; Gaul C; Weber K; Herbers J; Akhtar M; Ljungberg B; Kovacs G Lab Invest; 1997 Feb; 76(2):203-8. PubMed ID: 9042156 [TBL] [Abstract][Full Text] [Related]
28. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474 [TBL] [Abstract][Full Text] [Related]
29. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours. Kovacs G World J Urol; 1994; 12(2):64-8. PubMed ID: 8087142 [TBL] [Abstract][Full Text] [Related]
30. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma. Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376 [TBL] [Abstract][Full Text] [Related]
31. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214 [TBL] [Abstract][Full Text] [Related]
32. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour. Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715 [TBL] [Abstract][Full Text] [Related]
33. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000 [TBL] [Abstract][Full Text] [Related]
34. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Bugert P; Kovacs G Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267 [TBL] [Abstract][Full Text] [Related]
36. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma. Chino K; Esumi M; Ishida H; Okada K J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097 [TBL] [Abstract][Full Text] [Related]
37. Regional loss of chromosome 6 in two urological malignancies. Rukstalis DB; Bubley GJ; Donahue JP; Richie JP; Seidman JG; DeWolf WC Cancer Res; 1989 Sep; 49(18):5087-90. PubMed ID: 2766279 [TBL] [Abstract][Full Text] [Related]
38. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Nagy A; Wilhelm M; Sükösd F; Ljungberg B; Kovacs G Genes Chromosomes Cancer; 2002 Nov; 35(3):256-60. PubMed ID: 12353267 [TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. Presti JC; Moch H; Reuter VE; Cordon-Cardo C; Waldman FM J Urol; 1996 Jul; 156(1):281-5. PubMed ID: 8648824 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]